5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft. [electronic resource]
Producer: 20140722Description: 1737-47 p. digitalISSN:- 1949-2553
- Animals
- Antimetabolites, Antineoplastic -- pharmacology
- Azacitidine -- pharmacology
- Brain Neoplasms -- drug therapy
- Cell Differentiation -- drug effects
- Cell Growth Processes -- drug effects
- Cell Line, Tumor
- DNA Methylation -- drug effects
- Female
- Glioma -- drug therapy
- Humans
- Immunohistochemistry
- Isocitrate Dehydrogenase -- genetics
- Male
- Mice
- Mice, Nude
- Mutation
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.